Congress Extends Special Diabetes Program, Securing Long-Term Funding for T1D Research

Congress has passed bipartisan legislation to extend the Special Diabetes Program (SDP), a major source of federal funding for type 1 diabetes research. The President has signed the legislation into law, marking a significant commitment to advancing T1D treatments and understanding the disease.

The extension ensures that the research community will have predictable, continued funding to pursue emerging therapies and improve outcomes for people living with T1D and their families. The bipartisan nature of the legislation demonstrates broad agreement on the importance of investing in T1D research.

The Special Diabetes Program was established by Congress in 1997 and is administered by the National Institutes of Health (NIH). Since its creation, the program has invested nearly $3.6 billion in T1D research.

The SDP has played a role in nearly every major breakthrough in the T1D field, from advances in disease management to the development of therapies that delay the onset of type 1 diabetes. This track record demonstrates how sustained federal investment in research can translate into real progress for patients.

The extension of the Special Diabetes Program reflects ongoing advocacy efforts by the T1D community. Breakthrough T1D (formerly JDRF) and other advocates engaged directly with Congress through thousands of emails and hundreds of meetings over recent months to support the renewal.

In January, Breakthrough T1D organized a Capitol Hill briefing bringing together lawmakers, federal research leaders, scientists, and individuals living with T1D. The briefing highlighted how predictable federal funding accelerates progress across the research pipeline and improves outcomes for families nationwide.

The extension of the Special Diabetes Program provides the research community with the stability needed to pursue long-term research goals. Consistent funding allows scientists to investigate new approaches to prevention, treatment, and management of type 1 diabetes.

The T1D community continues to work toward better treatments and, ultimately, a cure. Federal programs like the Special Diabetes Program are essential to supporting the scientists and researchers who are advancing that mission.

Origin: breakthrought1d.org (News report). Evidence: News report — unverified, pending corroboration. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.